Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
Epigallocatechin Gallate
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021
Ergosterol
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Eryvarin M
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Euscaphic acid
Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021
Flaviolin
Potential treatment - theoretical effect Natural product Antiviral Sep/02/2020
Folic acid
Potential treatment - theoretical effect Natural product Antiviral Sep/24/2020
Forsythiaside
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Forsythoside I
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
FRIL
Potential treatment - pre-clinical evidence Natural product Antiviral Jul/24/2020
Futalosine
Potential treatment - theoretical effect Natural product Antiviral Jan/08/2021
Galangin
Potential treatment - theoretical effect Natural product Antiviral Aug/18/2020
Gallic acid
Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021
Gallocatechin gallate
Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020
Ganoderma lucidum extract fraction RF3
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021
Gartanin
Potential treatment - theoretical effect Natural product Antiviral Feb/01/2021
Gedunin
Potential treatment - theoretical effect Natural product Antiviral Oct/16/2020
Geraniin
Potential treatment - theoretical effect Natural product Antiviral Dec/03/2020
Gingerol
Potential treatment - theoretical effect Natural product Antiviral Feb/03/2021
Ginkgetin
Potential treatment - theoretical effect Natural product Antiviral Nov/03/2020
Ginkgo biloba leaves extract
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021